摘要
目的:肝细胞性肝癌组织浸润淋巴细胞与外周血T细胞表型可能与肿瘤进展及预后相关,本研究检测肝癌患者组织及外周血T细胞表型与分布,分析淋巴细胞表型变化与预后的关系。方法:分析2007年10月至12月中山医院147例肝癌及癌旁组织浸润淋巴细胞表型(T细胞或B细胞表面标志物:CD3、CD8、CD4、CD20、CD19、Foxp3),表型与临床病理特征及预后的关系;检测26例肝癌外周血CD3、CD8、CD4+T细胞数量并其比例变化。结果:癌巢内肿瘤浸润细胞明显少于癌周组织(P<0.01),癌周淋巴细胞主要分布于癌旁正常肝组织、汇管区,其与患者肝炎病史及肝硬化相关,表型以CD3+T细胞为主,其中又以CD8+细胞毒性T细胞为主;CD4染色在多数病例为阴性,Foxp3仅在个别病例(15/109)呈阳性。肿瘤浸润淋巴细胞B细胞标志CD20、CD19均为阴性。肿瘤组织内CD8+T细胞浸润数量与预后正相关,而癌周浸润淋巴细胞数目与患者转移及复发无显著关系。结论:肝癌肿瘤浸润细胞在癌巢内明显少于癌周组织,肿瘤及癌周浸润细胞以CD8+细胞毒性T细胞为主。肿瘤组织内CD8+T细胞浸润数量与预后相关,而癌周浸润淋巴细胞数量与患者转移及复发无显著关系。
Objective: To identify the signature of tumor-infiltrating lymphocyte (TIL) subtypes that may affect cytokine expres- sion between different outcomes of hepatocellular carcinoma (HCC) patients by analyzing the CD molecular expression profiles of non- cancerous hepatic tissues. Methods: Surface markers of TIL in noncancerous hepatic tissues from 146 HCC patients were determined by using immunohistochemical method and flow cytometry. Univariate and multivariate Cox proportional hazards models and Kaplan- Meier method were used to analyze the association of their expression levels with tumor recurrence and survival. Results: More than 86.4% of TILs in patients were quiescent, as measured via CD4+ or Foxp3 expression. Meanwhile, more than 90% of CD3+T cells ex- pressed CDS+. The proportion of T cells was low compared with CDS+ T cells. The proportion of CD 19 and CD20 in distant nontumor tissues almost was zero. The proportion of T cell subgroups isolated from HCC circulating whole blood did not show a significant shift compared with the normal control, as follows: CD4+T/CDS+T = 1.167 ± 1.04, CDS+ T/CD3+T = 0.288 ± 0.116, and CD4+T/CD3+T = 0.429 ± 0.178. The proportion of CDS+T cells in noncancerous hepatic tissues was higher than that in blood (P〈0.001).Conclusion: TILs in HCC noncancerous hepatic tissues are increased and contain a subpopulation of CD3+CD8+T cells. CDS+T cells in cancerous tissues, rather than noncancerous tissues, show significant differences between different prognostic groups.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2015年第11期559-563,共5页
Chinese Journal of Clinical Oncology
关键词
肿瘤浸润淋巴细胞
肝癌
表型
预后
tumor-infiltrating lymphocyte, hepatocellular carcinoma, phenotype, prognosis